Abridge vs Insilico Medicine

Abridge is a clinical documentation AI that listens to doctor-patient conversations and generates structured clinical notes in real time — attacking one of medicine's biggest burnout drivers: hours of paperwork after every shift.

During a visit, Abridge's ambient AI captures the conversation and converts it into a draft note in proper clinical structure, mapping spoken discussion to medical terminology and coding requirements, with links back to the source audio so clinicians can verify anything. It integrates directly into major EHR systems (notably Epic), so notes land where the workflow already lives, and supports multiple languages for diverse patient populations.

It's enterprise h…

Insilico Medicine uses generative AI, deep learning, and robotics to accelerate drug discovery and development. Its Pharma.AI platform supports target identification, molecule generation, and clinical trial prediction. The company has developed multiple AI-discovered drug candidates, including therapies that have advanced into clinical trials. Insilico combines biological data, chemistry models, and automated laboratories to reduce drug development timelines. Its work focuses on oncology, fibrosis, and age-related diseases.